Researchers evaluated whether pregnancy complications, early childhood characteristics, and tobacco-related exposures were ...

The first oral GLP-1 weight-loss pill, which contains semaglutide, became available nationwide Monday, January 5.

Researchers assessed the risk for serious infection during pregnancy and postpartum based on TNF inhibitor exposure among women with chronic inflammatory disease.

Statin initiation was associated with reductions in all-cause mortality and major CVD among adults with type 2 diabetes.

Continuing 5-ASA after escalation to advanced therapy in ulcerative colitis is associated with lower odds of clinical remission.

The US Centers for Disease Control and Prevention reduced the number of diseases protected by routine childhood vaccines from 17 to 11.

Background mucosal inflammation at CRC diagnosis is linked to worse recurrence-free and cancer-specific survival in ulcerative colitis.

Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

The US Centers for Disease Control and Prevention reported the highest number of measles cases in decades amid decreasing vaccination rates.

Maternal oral corticosteroid use during pregnancy is not associated with a substantially increased risk for gestational diabetes.

Semaglutide use was linked to lower rates of hospitalization in adults with established cardiovascular disease and higher BMI.

The Food and Drug Administration has approved Nereus (tradipitant) for the prevention of vomiting induced by motion in adults.